Odiparcil For The Prevention Of Venous Thromboembolism

PHASE2CompletedINTERVENTIONAL
Enrollment

961

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

September 30, 2006

Conditions
Deep Vein ThrombosisFibrillation, AtrialVenous ThromboembolismPulmonary Embolism
Interventions
DRUG

Odiparcil

DRUG

Warfarin

DRUG

Coumadin

Trial Locations (101)

157

GSK Investigational Site, Centurion

2050

GSK Investigational Site, Camperdown

3128

GSK Investigational Site, Box Hill

3135

GSK Investigational Site, Ringwood East

3168

GSK Investigational Site, Clayton

3181

GSK Investigational Site, Windsor

3220

GSK Investigational Site, Geelong

4215

GSK Investigational Site, Southport

11501

GSK Investigational Site, Mineola

16601

GSK Investigational Site, Altoona

17011

GSK Investigational Site, Camp Hill

17033

GSK Investigational Site, Hershey

18009

GSK Investigational Site, Cherkasy

18103

GSK Investigational Site, Allentown

19107

GSK Investigational Site, Philadelphia

19140

GSK Investigational Site, Philadelphia

21032

GSK Investigational Site, Vinnitsa

21209

GSK Investigational Site, Baltimore

21218

GSK Investigational Site, Baltimore

23229

GSK Investigational Site, Richmond

23249

GSK Investigational Site, Richmond

23507

GSK Investigational Site, Norfolk

25701

GSK Investigational Site, Huntington

27704

GSK Investigational Site, Durham

28207

GSK Investigational Site, Charlotte

30033

GSK Investigational Site, Decatur

31096

GSK Investigational Site, Haifa

32216

GSK Investigational Site, Jacksonville

32720

GSK Investigational Site, DeLand

33701

GSK Investigational Site, St. Petersburg

33756

GSK Investigational Site, Clearwater

34239

GSK Investigational Site, Sarasota

GSK Investigational Site, Sarsota

35209

GSK Investigational Site, Birmingham

36608

GSK Investigational Site, Mobile

40509

GSK Investigational Site, Lexington

43614

GSK Investigational Site, Toledo

44195

GSK Investigational Site, Cleveland

44281

GSK Investigational Site, Kfar Saba

45242

GSK Investigational Site, Cincinnati

48089

GSK Investigational Site, Warren

49005

GSK Investigational Site, Dnipro

49372

GSK Investigational Site, Petah Tikva

54449

GSK Investigational Site, Marshfield

64239

GSK Investigational Site, Tel Aviv

70808

GSK Investigational Site, Baton Rouge

72205

GSK Investigational Site, Little Rock

75231

GSK Investigational Site, Dallas

75246

GSK Investigational Site, Dallas

78217

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

79410

GSK Investigational Site, Lubbock

80124

GSK Investigational Site, Lonetree

80907

GSK Investigational Site, Colorado Springs

83702

GSK Investigational Site, Boise

85023

GSK Investigational Site, Phoenix

90509

GSK Investigational Site, Torrance

92220

GSK Investigational Site, Banning

95817

GSK Investigational Site, Sacramento

95991

GSK Investigational Site, Yuba City

115516

GSK Investigational Site, Mosocow

117415

GSK Investigational Site, Moscow

117593

GSK Investigational Site, Mosocow

344718

GSK Investigational Site, Rostov-on-Don

640014

GSK Investigational Site, Kurgan

664003

GSK Investigational Site, Irkutsk

21215-5271

GSK Investigational Site, Baltimore

90020-090

GSK Investigational Site, Porto Alegre

90035-903

GSK Investigational Site, Porto Alegre

R3J 3M7

GSK Investigational Site, Winnipeg

L1S 2J5

GSK Investigational Site, Ajax

M3C 1W3

GSK Investigational Site, Don Mills

L3Y 2P9

GSK Investigational Site, Newmarket

M3M 2G2

GSK Investigational Site, North York

L1G 2B9

GSK Investigational Site, Oshawa

M1W 3W3

GSK Investigational Site, Scarborough Village

N2J 1C4

GSK Investigational Site, Waterloo

C1A 1L2

GSK Investigational Site, Charlottetown

H1T 2M4

GSK Investigational Site, Montreal

G1J 1Z4

GSK Investigational Site, Québec

J7Z 5T3

GSK Investigational Site, Sainte Jerome

600 040

GSK Investigational Site, Chennai

500 003

GSK Investigational Site, Secunderabad

LV1004

GSK Investigational Site, Riga

LV1005

GSK Investigational Site, Riga

LT-50009

GSK Investigational Site, Kaunas

LT-92288

GSK Investigational Site, Klaipėda

LT-04128

GSK Investigational Site, Vilnius

15-276

GSK Investigational Site, Bialystok

31-862

GSK Investigational Site, Krakow

41-200

GSK Investigational Site, Sosnowiec

50-043

GSK Investigational Site, Wroclaw

0084

GSK Investigational Site, Pretoria

Unknown

GSK Investigational Site, Pretoria

03103

GSK Investigational Site, Kyiv

04107

GSK Investigational Site, Kyiv

B18 7QH

GSK Investigational Site, Birmingham

BH7 7DW

GSK Investigational Site, Bournmouth

KY2 5AH

GSK Investigational Site, Fife

SE5 9JP

GSK Investigational Site, London

WN6 9EP

GSK Investigational Site, Wigan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00244725 - Odiparcil For The Prevention Of Venous Thromboembolism | Biotech Hunter | Biotech Hunter